{
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3748, 
        3771
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3143, 
        3170
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3096, 
        3105
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3123, 
        3132
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        574, 
        603
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3671, 
        3706
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3052, 
        3078
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3297, 
        3334
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3351, 
        3444
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3481, 
        3518
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3541, 
        3578
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3080, 
        3086
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3088, 
        3094
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3106, 
        3121
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3133, 
        3140
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3172, 
        3178
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3184, 
        3190
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3205, 
        3220
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3221, 
        3228
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3289, 
        3295
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3338, 
        3349
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3532, 
        3539
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3613, 
        3628
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3469, 
        3479
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1053014^CLIA|eMARCPlus|TN Cancer Registry|20170919125824||ORU^R01^ORU_R01|201709191258240001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-21-007887^PathSys^44D1053014^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170807000000|||||||20170807000000|&Uterus w/ Tubes &amp; Ovaries, other than NEO/PRO|1346270014^ ^ ^M^^^MD^^CMS^D^^^NPI||||||20170811000000|||F||||||C18.9^Malignant neoplasm of colon, unspecified^I10~Z84.81^Family history of carrier of genetic disease^I10|1942526447&&&S&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nReceived in formalin labeled \", uterus, cervix, bilateral fallopian tubes, bilateral ovaries\" is a uterus with attached bilateral adnexa. After removal of the adnexa the uterus weighs 45 g, and measures 17.0 cm from superior to inferior, 3.5 cm from cornu to cornu, and 2.8 cm from anterior to posterior. The serosa is tan-pink, diffusely hyperemic and smooth with one, 0.5 x 0.3 x 0.1 cm nodule on the anterior surface. The attached portion of cervix measures 2.6 x 2.5 x 2.5 cm. The ectocervix is pink-red to red-purple with diffusely pink-red to red-purple and smooth with a slit-like cervical os measuring 0.7 cm in diameter. The specimen is opened to reveal a tan-pink, trabecular and endocervical canal with a few nabothian cyst. The endometrial cavity measures 2.7 x 2.3 cm and is lined with tan-pink glistening mucosa. Sectioning reveals a maximum endometrial thickness of 0.2 cm. The underlying myometrium is tan-pink, finely trabecular and measures 1.3 cm in maximum thickness. The right adnexa weighs 8 g, the right ovary measures 2.0 x 0.7 x 0.5 cm. Bisecting the ovary reveals tan-pink, glistening cut surfaces. The right fallopian tube measures 6.8 cm in length x 0.4 cm in diameter and is fimbriated. The serosal surface is tan- pink, smooth and glistening. Sectioning reveals tan-pink unremarkable cut surfaces. The left adnexa weighs 8 g. The left ovary measures 2.5 x 0.7 x 0.4 cm. The outer surface is tan-pink, glistening and lobular. Sectioning the ovary reveals tan-pink cut surfaces with a 0.2 cm in greatest dimension cystic cavity filled with clear serous fluid. The cyst wall is smooth and glistening. No excrescences are identified grossly. The left fallopian tube measures 6.5 cm in length x 0.4 cm in diameter and is fimbriated. The serosal surface is tan-pink, focally hyperemic with a focal area of adhesions. Serial sectioning reveals tan-pink, unremarkable cut surfaces. Representative sections are submitted as follows: 1A, cervix, 2/1; 1B, full thickness anterior endomyometrium, 1/1; 1C, full thickness posterior endomyometrium, 1/1; 1D, serosal nodule, 1/1; 1E, right ovary and fallopian tube, 3/1; 1F, left ovary and fallopian tube, 4/1. (AC2) Additional sections to include the entire endometrium and remaining ovarian parenchyma are submitted on 8/8/17 as follows: 1G-1H right ovary G1/1, H2/1; 1I-1J left ovary I2/1, J4/1; 1K-1M entire anterior endometrium 3/1 each; 1N-1O entire posterior endometriuim.\n\n\nPath report.site of origin\n\nUterus, cervix, bilateral fallopian tubes, bilateral ovaries\n\n\nPath report.final diagnosis\n\nUterus with cervix and bilateral fallopian tubes/ovaries, total hysterectomy with bilateral salpingo-oophorectomy:   Cervix: No significant histopathologic change.   Endometrium: Proliferative endometrium; negative for atypical hyperplasia/EIN,     dysplasia or malignancy (entirely submitted).   Myometrium: No significant histopathologic change.   Bilateral ovaries: No significant histopathologic change (entirely submitted).   Bilateral fallopian tubes: No significant histopathologic change.\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Post meiotic segregation 2-related Lynch syndrome\n\n\n"
}